Stay updated on AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial

Sign up to get notified when there's something new on the AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.8.1 instead of v3.8.0.
    Difference
    0.0%
    Check dated 2026-11-18T03:00:48.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The error page has been replaced by the completed Phase 3 ATTRibute-CM study record, with details on the treatment and outcomes, eligibility, study locations, and supporting documents.
    Difference
    100%
    Check dated 2026-11-11T02:03:31.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0; the page still shows a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-04T00:33:10.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    An NIH-wide notice about terminology changes appears above the 403 error page, and the site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:34:22.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T00:42:27.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The study record page is currently returning a 403 Forbidden error, blocking access to the study details and related information on the page. Users cannot view documents, locations, or other study data.
    Difference
    18%
    Check dated 2026-09-23T01:02:28.000Z thumbnail image

Stay in the know with updates to AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial page.